Objectives: The objectives of the study are to assess the quality of sleep and its associated factors in newly diagnosed patients with opioid use disorder (OUD), particularly during the early stages of treatment. Material and Methods: This cross-sectional observational study was conducted at the Deaddiction Outpatient Department of KEM Hospital. Eighty participants with newly diagnosed OUD were recruited using comprehensive enumeration. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI), and socio-demographic and opioid use data were collected through a semi-structured pro forma. Results: The mean global PSQI score was 10.16, with 80% of participants scoring above 5, indicating poor sleep quality. Statistical analysis revealed no significant associations between PSQI scores and variables such as age, gender, marital status, occupation, opioid use patterns, or family structure. Conclusion: Poor sleep quality is highly prevalent among patients with OUD, regardless of demographic or substance use characteristics. These findings underscore the importance of incorporating sleep-focused interventions into comprehensive substance use treatment plans.
Gadgile et al. (Thu,) studied this question.